Integrated regulation of very low density lipoprotein triglyceride and apolipoprotein-B kinetics in man: normolipemic subjects, familial hypertriglyceridemia and familial combined hyperlipidemia - PubMed (original) (raw)
Integrated regulation of very low density lipoprotein triglyceride and apolipoprotein-B kinetics in man: normolipemic subjects, familial hypertriglyceridemia and familial combined hyperlipidemia
A H Kissebah et al. Metabolism. 1981 Sep.
Abstract
Turnover kinetics of triglycerides (TG) and apolipoprotein-B (apo-B) of plasma very low density lipoprotein (VLDL) and their relationship to plasma VLDL composition and VLDL apo-B conversion to low density lipoprotein (LDL) were determined in age and weight-matched groups of normolipemic (NL) healthy subjects, patients with familial combined hyperlipidemia (FCHL) and patients with familial hypertriglyceridemia (FHTG). In NL subjects, a significant correlation as observed between VLDL TG or VLDL apo-B turnover rate and its circulating mass, suggesting that the plasma level of VLDL was determined by the secretion rate of VLDL TG and apo-B. The positive significant correlation between VLDL TG and apo-B also suggests that the production of these moieties was integrated at the synthetic and/or secretory sites to maintain the ratio of TG to apo-B in plasma VLDL. In moderately obese NL subjects, proportionate increases in VLDL TG and apo-B turnover rates resulted in enhanced secretion of VLDL particles. Both groups with genetic hypertriglyceridemia had increased VLDL TG and VLDL apo-B turnover rates. This increase accounted for the increase in circulating VLDL TG and apo-B mass. In patients with FCHL, turnover rates of VLDL TG and apo-B were equally increased, hence, the ratios between major VLDL constituents were within normal limits. On the other hand, the increase in VLDL TG turnover in patients with FHTG was disproportionately greater than that of apo-B resulting in a higher ratio of TG to other VLDL components. In NL subjects, approximately 72% of VLDL apo-B released into plasma was converted to LDL. This conversion correlated positively with VLDL apo-B turnover rate and inversely with VLDL TG turnover rate. Formation of LDL from VLDL was significantly greater in the obese individuals. In FCHL, conversion of VLDL to LDL represented the major pathway for VLDL apo-B catabolism. The increased VLDL apo-B load was predominantly catabolized to LDL. The greater increase in VLDL TG turnover relative to apo-B in FHTG, on the other hand, resulted in a smaller fraction of VLDL apo-B recovered in LDL, most of the VLDL apo-B being removed via a pathway that did not involve this conversion. We conclude that the composition and metabolic fate of plasma VLDL may be greatly influenced by the secretion rates of VLDL TG and apo-B. If VLDL conversion to LDL and the subsequent catabolism of the latter provides a major route for delivery of cholesterol ester to peripheral tissues, then the increased LDL production in FCHL compared to FHTG may account for a higher cardiovascular risk.
Similar articles
- Integrated regulation of very low density lipoprotein triglyceride and apolipoprotein-B kinetics in non-insulin-dependent diabetes mellitus.
Kissebah AH, Alfarsi S, Evans DJ, Adams PW. Kissebah AH, et al. Diabetes. 1982 Mar;31(3):217-25. doi: 10.2337/diab.31.3.217. Diabetes. 1982. PMID: 7152129 - Plasma lipoproteins in familial combined hyperlipidemia and monogenic familial hypertriglyceridemia.
Brunzell JD, Albers JJ, Chait A, Grundy SM, Groszek E, McDonald GB. Brunzell JD, et al. J Lipid Res. 1983 Feb;24(2):147-55. J Lipid Res. 1983. PMID: 6403642 - Low density lipoprotein metabolism in familial combined hyperlipidemia. Mechanism of the multiple lipoprotein phenotypic expression.
Kissebah AH, Alfarsi S, Evans DJ. Kissebah AH, et al. Arteriosclerosis. 1984 Nov-Dec;4(6):614-24. doi: 10.1161/01.atv.4.6.614. Arteriosclerosis. 1984. PMID: 6508636 - Omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid and their mechanisms of action on apolipoprotein B-containing lipoproteins in humans: a review.
Oscarsson J, Hurt-Camejo E. Oscarsson J, et al. Lipids Health Dis. 2017 Aug 10;16(1):149. doi: 10.1186/s12944-017-0541-3. Lipids Health Dis. 2017. PMID: 28797250 Free PMC article. Review. - In vivo studies of VLDL metabolism and LDL heterogeneity.
Demant T, Packard C. Demant T, et al. Eur Heart J. 1998 Jul;19 Suppl H:H7-10. Eur Heart J. 1998. PMID: 9717058 Review.
Cited by
- Predicting the 10-year incidence of dyslipidemia based on novel anthropometric indices, using data mining.
Takhttavous A, Saberi-Karimian M, Hafezi SG, Esmaily H, Hosseini M, Ferns GA, Amirfakhrian E, Ghamsary M, Ghayour-Mobarhan M, Alinezhad-Namaghi M. Takhttavous A, et al. Lipids Health Dis. 2024 Jan 31;23(1):33. doi: 10.1186/s12944-024-02006-2. Lipids Health Dis. 2024. PMID: 38297277 Free PMC article. - Physiological Bases for the Superiority of Apolipoprotein B Over Low-Density Lipoprotein Cholesterol and Non-High-Density Lipoprotein Cholesterol as a Marker of Cardiovascular Risk.
Glavinovic T, Thanassoulis G, de Graaf J, Couture P, Hegele RA, Sniderman AD. Glavinovic T, et al. J Am Heart Assoc. 2022 Oct 18;11(20):e025858. doi: 10.1161/JAHA.122.025858. Epub 2022 Oct 10. J Am Heart Assoc. 2022. PMID: 36216435 Free PMC article. Review. - A Positive Association between the Atherogenic Index of Plasma and White Matter Hyperintensity.
Kwon HS, Ko JS, Lee JH, Kwon KY, Han JH. Kwon HS, et al. Korean J Fam Med. 2022 May;43(3):193-198. doi: 10.4082/kjfm.21.0129. Epub 2022 May 20. Korean J Fam Med. 2022. PMID: 35610965 Free PMC article. - PSRC1 May Affect Coronary Artery Disease Risk by Altering CELSR2, PSRC1, and SORT1 Gene Expression and Circulating Granulin and Apolipoprotein B Protein Levels.
Chai T, Wang Z, Yang X, Qiu Z, Chen L. Chai T, et al. Front Cardiovasc Med. 2022 Feb 18;9:763015. doi: 10.3389/fcvm.2022.763015. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 35252377 Free PMC article. - Secular changes in mid-adulthood body mass index, waist circumference, and low HDL cholesterol between 1990, 2003, and 2018 in Great Britain.
Johnson W, Norris T, Hamer M. Johnson W, et al. Eur J Clin Nutr. 2021 Mar;75(3):539-545. doi: 10.1038/s41430-020-00758-5. Epub 2020 Sep 16. Eur J Clin Nutr. 2021. PMID: 32939041 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous